Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al
Osteoporos Int
.
2018 Sep;29(9):2159-2160.
doi: 10.1007/s00198-018-4615-5.
Epub 2018 Jul 16.
Authors
J Bergman
1
,
A Nordström
2
3
,
P Nordström
4
Affiliations
1
Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, 90187, Umeå, Sweden.
2
Department of Public Health and Clinical Medicine, Unit of Occupational and Environmental Medicine, Umeå University, Umeå, Sweden.
3
School of Sport Sciences, Arctic University of Norway, Tromsø, Norway.
4
Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, 90187, Umeå, Sweden.
[email protected]
.
PMID:
30014156
DOI:
10.1007/s00198-018-4615-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Bone Density Conservation Agents*
Diphosphonates
Fractures, Bone*
Humans
Substances
Bone Density Conservation Agents
Diphosphonates